Abstract
Crohns disease is an inflammatory bowel disease associated with several changes in the immune system, including an increased number of infiltrating macrophages. These macrophages release a variety of proinflammatory cytokines, such as tumor necrosis factor-α (TNF-α), macrophage infiltrating factor (MIF), interleukin (IL)-6, IL-12 and IL-18, which are critically involved in the onset and the development of Crohns disease. We here focus on the role of macrophages, especially macrophagederived IL-18 in both patients with Crohns disease and a murine model of Crohns disease.
Keywords: crohns disease, proinflammatory cytokines, il-18, immunotoxin, targeting
Current Drug Targets - Inflammation & Allergy
Title: Macrophage-Derived IL-18 Targeting for the Treatment of Crohns Disease
Volume: 2 Issue: 2
Author(s): Takanori Kanai, Koji Uraushihara, Teruji Totsuka, Akira Okazawa, Toshifumi Hibi, Shigeru Oshima, Tatsuya Miyata, Tetsuya Nakamura and Mamoru Watanabe
Affiliation:
Keywords: crohns disease, proinflammatory cytokines, il-18, immunotoxin, targeting
Abstract: Crohns disease is an inflammatory bowel disease associated with several changes in the immune system, including an increased number of infiltrating macrophages. These macrophages release a variety of proinflammatory cytokines, such as tumor necrosis factor-α (TNF-α), macrophage infiltrating factor (MIF), interleukin (IL)-6, IL-12 and IL-18, which are critically involved in the onset and the development of Crohns disease. We here focus on the role of macrophages, especially macrophagederived IL-18 in both patients with Crohns disease and a murine model of Crohns disease.
Export Options
About this article
Cite this article as:
Kanai Takanori, Uraushihara Koji, Totsuka Teruji, Okazawa Akira, Hibi Toshifumi, Oshima Shigeru, Miyata Tatsuya, Nakamura Tetsuya and Watanabe Mamoru, Macrophage-Derived IL-18 Targeting for the Treatment of Crohns Disease, Current Drug Targets - Inflammation & Allergy 2003; 2 (2) . https://dx.doi.org/10.2174/1568010033484250
DOI https://dx.doi.org/10.2174/1568010033484250 |
Print ISSN 1568-010X |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-010X |
Related Articles
-
Biospecific Interaction Analysis (BIA) as a Tool for the Design and Development of Gene Transcription Modifiers
Current Medicinal Chemistry - Anti-Cancer Agents Action Mechanisms of Chinese Herbal Compound at the Molecular Level
Letters in Drug Design & Discovery <i>Holothuria arenicola</i> Extract Attenuated Hepatic Steatosis in Splenectomized Rat Fed High Fat Diet
The Natural Products Journal Treatment of Inflammatory Diseases with Mesenchymal Stem Cells
Inflammation & Allergy - Drug Targets (Discontinued) Drug Discovery by Drug Repurposing: Combating COVID-19 in the 21st Century
Mini-Reviews in Medicinal Chemistry Mesenchymal Stem Cells Targeting of Systemic Disorders in Age-related Macular Degeneration
Current Tissue Engineering (Discontinued) The Arrestin Fold: Variations on a Theme
Current Genomics Combinatorial Protein Biochemistry for Therapeutics and Proteomics
Current Pharmaceutical Biotechnology The Heat Stress Response and Diabetes: More Room for Mitochondrial Implication
Current Pharmaceutical Design Crosstalk between Microglia and Neurons in Neurotrauma: An Overview of the Underlying Mechanisms
Current Neuropharmacology Compounds From Celastraceae Targeting Cancer Pathways and Their Potential Application in Head and Neck Squamous Cell Carcinoma: A Review
Current Genomics Molecule of the Month
Current Topics in Medicinal Chemistry Gender Disparity in Pediatric Diseases
Current Molecular Medicine Blood-based Amyloid and Tau Biomarker Tests For Alzheimer’s Disease
Neuroscience and Biomedical Engineering (Discontinued) Beneficial Effects of Statins on Endothelial Dysfunction and Vascular Stiffness
Current Vascular Pharmacology Neovascular Age-related Macular Degeneration: Past, Present, and Future
Current Angiogenesis (Discontinued) Therapeutic Potential of Drug Delivery by Means of Lipid Nanoparticles: Reality or İllusion?
Current Pharmaceutical Design Specific Immune Intervention with Monoclonal Antibodies for the Treatment of Multiple Sclerosis
Current Medicinal Chemistry The Impetus of COVID -19 in Multiple Organ Affliction Apart from Respiratory Infection: Pathogenesis, Diagnostic Measures and Current Treatment Strategy
Infectious Disorders - Drug Targets Qualitative and Quantitative Chemometry as Stability-Indicating Methods for Determination of Dantrolene Sodium and Paracetamol
Current Pharmaceutical Analysis